หมวดหมู่: ไม่มีหมวดหมู่
-
USAS Building System Advances Toward Hong Kong Listing: A Top-Three Industrial Prefabricated Steel Structure Solution Provider, with an Emerging Overseas Growth Curve
HONG KONG, Dec. 29, 2025 /PRNewswire/ — With manufactu…
-
Goodix Leads the Era of Bluetooth® 6.1 High-Precision Ranging with Next-Gen Automotive-Grade Bluetooth LE SoC
SHENZHEN, China, Dec. 29, 2025 /PRNewswire/ — Imagine …
-
CCTV+: China-Lao Agricultural Science Cooperation Delivers New Results in 2025
BEIJING, Dec. 29, 2025 /PRNewswire/ — China and Lao PD…
-
HKSH Medical Group and Southern University of Science and Technology Collaborate for Medical and Medical Physics Training, Enhancing Medical Education and Research Innovation
HONG KONG, Dec. 29, 2025 /PRNewswire/ — HKSH Medical G…
-
Shanghai unveils steps to build sci-tech innovation corridor in Yangtze River Delta
SHANGHAI, Dec. 29, 2025 /PRNewswire/ — A news report f…
-
GEEKOM Returns to CES 2026 with Premium Laptops and Next-Generation Mini PCs
TAIPEI, Dec. 29, 2025 /PRNewswire/ — GEEKOM will make …
-
Global Times: Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era receives high recognition from intl community: 2025 Global Survey on Impression and Understanding of China
BEIJING, Dec. 29, 2025 /PRNewswire/ — In 2025, the wor…
-
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
Thai investors now can trade in real-time during local …
-
Adventures in DMPK: Viva Biotech’s One-Stop Pharmacology Platform Cross New Modalities
SHANGHAI, Dec. 29, 2025 /PRNewswire/ — Drug Pharmacoki…
-
Alphamab Oncology Announces IND Application for a Phase II Clinical Study of HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 as First-line Treatment of Advanced Cervical Cancer was Officially Accepted by CDE
SUZHOU, China, Dec. 29, 2025 /PRNewswire/ — Alphamab O…